To map the distribution of anthrax outbreaks and strain subtypes in Kazakhstan during 1937-2005, we combined geographic information system technology and genetic analysis by using archived cultures and data. Biochemical and genetic tests confi rmed the identity of 93 archived cultures in the Kazakhstan National Culture Collection as Bacillus anthracis. Multilocus variable number tandem repeat analysis genotyping identifi ed 12 genotypes. Cluster analysis comparing these genotypes with previously published genotypes indicated that most (n = 78) isolates belonged to the previously described A1.a genetic cluster, 6 isolates belonged to the A3.b cluster, and 2 belonged to the A4 cluster. Two genotypes in the collection appeared to represent novel genetic sublineages; 1 of these isolates was from Krygystan. Our data provide a description of the historical, geographic, and genetic diversity of B. anthracis in this Central Asian region.
A nthrax is a globally widespread disease of livestock and wildlife that occasionally infects humans. According to offi cial estimates, the number of human anthrax cases worldwide ranges from 2,000 to 20,000 annually (1) .
Bacillus anthracis, the etiologic agent of anthrax, persists in the environment as a dormant, highly stable spore. The prolonged periods of dormancy during the spore phase slows evolution of this species, resulting in high levels of interstrain genetic homogeneity, which complicates efforts to subtype the pathogen. The availability of whole-genome nucleotide sequences of B. anthracis for single-nucleotide polymorphism (SNP) elucidation and the discovery of polymorphic markers such as variable number tandem repeat (VNTR) sequences (2, 3) have enabled identifi cation of unique subtypes within this species. Keim et al. (4) used 8 VNTRs to describe 89 unique genotypes in a global collection of over 400 B. anthracis isolates. Later studies used VNTRs to examine B. anthracis diversity in different global regions, including France (5), Italy (6) , Poland (7), Chad (8) , and South Africa (9) . More recently, SNPs that defi ne major clonal lineages in B. anthracis have been identifi ed and applied to describe global and regional patterns of B. anthracis diversity (10) .
In the central Asian republic of Kazakhstan, anthrax is enzootic and still represents a human public health concern. A recent publication examined risk factors associated with 73 human anthrax cases in Kazakhstan over a 2-year period (11) and concluded that most cases were cutaneous and had resulted from the handling of infected livestock and contaminated animal products. Gastrointestinal anthrax in Kazakhstan has also been reported but is less common. Despite the widespread nature of the disease in this region, the historical incidence, distribution, and genetic diversity of B. anthracis in central Asia, and Kazakhstan in particular, has remained cryptic.
We mapped the historical distribution of anthrax in Kazakhstan over a 68-year period. Archived cultures from a subset of these outbreaks collected from 10 oblasts (provinces) over a 53-year period were analyzed by using genetic and biochemical tests. Multilocus variable number tandem repeat analysis (MLVA) and canonical single nucleotide polymorphism genotyping (10) of this collection enabled us to examine strain dynamics among and within these outbreaks and to understand the diversity of B. anthracis isolates from Kazakhstan on a local, regional, and global scale.
Materials and Methods

Mapping Historical Anthrax Outbreaks
To map the historical distribution of anthrax outbreaks and B. anthracis strain types across Kazakhstan, we constructed a geographic information system (GIS) database within ArcGIS 9.1 (www.esri.com). This database used archival data collected through the antiplague stations established by the Union of Soviet Socialist Republics. This system of stations remains in place under the current government, and Kazakhstan maintains a multiagency reporting protocol to update, document, and respond to the distribution of outbreaks. These data are archived at the Kazakhstan Scientifi c Center for Quarantine and Zoonotic Diseases. Outbreaks and strain locations were geolocated to the nearest village by using GIS data layers produced by the Kazakh Institute of Geography. Historical outbreaks were mapped for 1937 through 2005. To illustrate differences in the distributions of outbreaks in cattle and sheep, the 2 most affected livestock species, a kernel density estimation was performed by using the Spatial Analyst Extension in ArcGIS. We mapped outputs by using the standard deviation of density values to illustrate areas of greatest outbreak concentration by species (12) .
Isolation of B. anthracis
Samples collected from anthrax outbreaks in Kazakhstan (with the exception of 2 isolates from the Kyrgyzstan border region) and cultures spanning a 53-year period were archived in the Kazakhstan National B. anthracis Collection. Most isolates were from human patients, some from blood or organs of ruminants (mainly sheep and cows), and a few from soil or other inanimate objects contaminated by contact with blood or tissues of infected animals. Archived cultures were confi rmed as B. anthracis on the basis of colony morphologic appearance; absence of hemolysis and catalase, lipase, phosphatase and protease activity; and susceptibility to B. anthracis-specifi c γ phage.
DNA Preparation
B. anthracis cultures from the Kazakhstan National Collection were grown on Hottinger blood agar. A colony from each sample was harvested from the agar plates and dispersed in Tris-EDTA buffer for DNA extraction. A QIAamp DNA Mini Kit (QIAGEN, Valencia, CA, USA) was used to extract genomic and plasmid DNA by using the manufacturer's protocol. A total of 1.0 mL of DNA was collected from each of the isolates in the collection.
MLVA Genotyping
Eight VNTR (MLVA-8) markers were amplifi ed by PCR by using primer pairs vrrA-f1 and vrrA-r1, vrrB 1 -f1 and vrrB 1 -r1, vrrB 2 -f1 and vrrB 2 -r1, vrrC 1 -f1 and vrrC 1 -r1, vrrC 2 -f1 and vrrC 2 -r1, CG3-f1 and CG3-r1, pXO1-AATf3 and pXO1-AAT-r3, and pXO2-AT-f1 and pXO2-AT-r1 (4). One microliter containing ≈1 ng of template DNA was added to each PCR.
Electrophoresis of amplifi ed products was performed on an ABI 310 genetic analyzer (Applied Biosystems, Inc., Foster City, CA, USA). Data were analyzed by using GeneMapper software V4.0 (Applied Biosystems, Inc.). To ensure comparability and accuracy of raw VNTR scores from the strains from Kazakhstan with the genotypes published by Keim et al. 2000 (4), we performed electrophoresis on amplifi ed fragments from 4 control DNAs (A0462-Ames, A0488-Vollum; A0071-Western North America and A0402; and French B2) in parallel with the isolates from Kazakhstan. In addition, DNA molecular size reference markers (Applied Biosystems, Inc) were included in each sample to accurately size the 8 VNTR fragments. Raw VNTR sizes were normalized to the sizes reported by Keim et al., 2000 (4) for genotypic comparisons.
Unweighted Pair Group Method with Arithmetic Mean Cluster Analysis of Genotypes
Unweighted pair group method with arithmetic mean (UPGMA) cluster analysis of VNTR data from 92 confi rmed B. anthracis isolates and the diverse 89 genotypes described by Keim et al. 2000 (4) were used to establish genetic relationships. Distance matrices were generated in PAUP 4.0 (Sinauer Associates, Inc., Sunderland, MA, USA) and imported into MEGA 3.1 (13) for tree-building purposes.
Spatial Patterns of Genetic Relationships
The strain database was constructed from museum records and contemporary epidemiologic investigations. This database was synchronized with the bacterial culture collection to geolocate the culture by using the GIS. To map strain diversity, we categorized culture collection locations by strain identifi cations based on the MLVA genotyping results.
SNP Typing of B. anthracis Isolates
Representative cultures from each Kazakh MLVA genotype plus the STI vaccine strain from Russia were genotyped by using previously described canonical SNPs discovered by whole-genome sequencing (10, 14) . SNPs were interrogated by using the Roche Light Cycler II realtime PCR instrument (Roche Diagnostics, Indianapolis, IN, USA). Allelic discrimination assays initially developed on the ABI 7900 real-time platform (10) were adapted for use on the Light Cycler II. The assay amplifi es a fragment of DNA sequence containing the SNP site. Two probes complementing the 2 potential SNP states were used as real time markers. Each probe had a distinct fl uorescent label; i.e., probe 1 was labeled with 6-carboxyfl uorescein, and the alternate probe was labeled with VIC (Applied Biosystems, Inc.). The probe complementary to the sequence in the sample amplicon will hybridize over the SNP and surrounding sequence during the amplifi cation process to generate a signal. It is possible for the incorrect probe to generate some signal but not enough to be confused as a positive reaction. The Light Cycler II discriminated which probe was the complementary sequence on the basis of the differential intensity of the reaction. Controls for each run included template DNA with both SNP states of interest.
Results
Historical Incidence and Geographic Distribution of Anthrax in Kazakhstan
A total of 1,037 human outbreaks were reported, representing 1,765 human cases. The outbreaks occurred in 665 locations; 198 of those locations reported repeat outbreaks throughout the study period ( Figure 1 ; Table 1 ). Additional review of historical data at the Kazakhstan Scientifi c Center for Quarantine and Zoonotic Diseases identifi ed 3,947 outbreak events reported for animal species and were entered into GIS. The outbreaks occurred over 1,790 locations; 805 of those reported repeated outbreaks.
Cattle and sheep were the primary livestock species affected during the study period; fewer outbreaks occurred among swine, and rarer, sporadic outbreaks occurred on mink farms and among foxes, and camels (Table 2) . Cattle outbreaks were most common in northern Kazakhstan; several outbreaks occurred in the southernmost oblasts bordering Uzbekistan and Kyrgyzstan (Figure 2 
Biochemical Tests
All cultures except 1 (isolate no. 49) were biochemically and morphologically consistent for B. anthracis; 3 cultures (isolate nos. 65, 76, and 77) were consistent with B. anthracis but did not exhibit capsule formation. With the exception of culture no. 49, isolates were nonhemolytic; nonmotile; phosphatase and lecithinase negative; protease, oxidase, and catalase positive; and, with 3 exceptions, formed a capsule.
MLVA Genotyping
Of the 92 B. anthracis isolates, 88 isolates yielded complete data for the 8 marker MLVA; 3 isolates were missing the pX02 marker (isolate nos. 65, 76, and 77), and 1 was missing the pX01 plasmid marker (isolate no. 7). After we coded the raw VNTR fragment sizes, the Kazakh B. anthracis genotypes were analyzed by using PAUP 4. (4) showed that most isolates (n = 78) belonged to the previously described A1.a genetic cluster; 6 isolates belonged to the A3.b cluster; and 2 isolates belonged to the A4 cluster. More than half of the A1.a isolates belong to previously described genotypes (38/74; excluding samples with missing pX01, pX02 data), including the previously described MLVA genotypes 3 (n = 15), 6 (n = 2) and 13 (n = 21). Most of the novel genotypes reported from the Kazakhstan National collection represent slight variants of previously described genotypes that can be explained by the insertion or deletion of >1 tandem repeats at a particular locus, usually in pX01 or pX02 (Table 3) . However, 2 of the genotypes from Kazakhstan (G kz -9 and -11) appear to represent new sublineages on the basis of newly described allele combinations and distance-based clustering with the diverse 89 genotypes. In addition, the pX01 allele sizing at position 138 appears novel (G kz -5); we have not seen this size reported in previous MLVA-8 studies (Table 3 ).
Geographic Distribution of MLVA Genotypes
The geographic distribution of MLVA types in Kazakhstan indicated that A1.a genotypes were widely distributed ( Figure 3 ). For example, the most common Kazakh genotype (G kz -1; n = 21) clusters on the GeorgiaKazakhstan border and on the southern border near Kyrgyzstan and Uzbekistan. The A1.a G kz -4 (n = 17) is also widely dispersed across Kazakhstan; cases have occurred in the western, southern, and eastern regions and into Kyrgyzstan. Specifi c genotypes within the Kazakh A1.a group appear to exhibit geographic clustering, refl ecting temporally linked outbreaks. The KZ genotypes 9-12 (G kz -9-12) also appear to be more geographically confi ned, although this apparent confi nement is likely a refl ection of sample size. For example, isolates with G kz -12 (n = 6; Figure 3 ) are exclusively found in the border region of the East Kazakhstan oblast, whereas the group 9 isolates (n = 5) are found in the Shymkent oblast in the south-central portion of the country. MLVA G kz -11 (n = 1), which appears to represent a previously unreported genetic lineage, was isolated just south of Kazakhstan in Kyrgyzstan.
SNP Typing
Representative cultures from each of the Kazakh MLVA genotypes plus the Russian STI vaccine were SNP genotyped by using allelic discrimination probes and the Light Cycler II instrument. The SNP results were compared (Table 4) with the SNP profi les of Van Ert et al. (10) , allowing assignment of the isolates to 1 of 12 sublineages. As with MLVA typing, all isolates tested with SNPs had genotypes characteristic of the A branches.
Representatives of MVLA genotypes 1-9 were assigned to A.Br.008/009, KZ genotype 10 to the A.Br.Vollum subgroup, and genotype 11 and 12 to the A.Br.Ames subgroup. The SNP data indicated that all representative A1.a Kazakh isolates belonged to the European branch of this group. The assignment of MLVA G kz -10 to the A.Br. Vollum group is consistent with B. anthracis found globally in areas such as Pakistan and western China (10). Likewise, the assignment of Kazakh MLVA genotypes 11 and 12 to the A.Br.Ames genotype is consistent with the presence of this lineage in China (10).
Discussion
The historical occurrence and geographic distribution of anthrax outbreaks in Kazakhstan suggest anthrax foci are heavily concentrated in the southern region and broadly distributed across the northern portions of the country but are less common in the central regions. This may refl ect regional differences in soil composition, availability of water and livestock and even case reporting. For example, the central region of Kazakhstan is dominated by desert, which likely has poor soils for long-term spore survival, whereas in the southern, northern, and eastern oblasts, the soils are more alkaline with higher organic matter and likely support spore survival (15) (16) (17) . From a temporal perspective, outbreaks (or outbreak reports) have decreased in severity (number of animals infected), frequency (number of reported outbreaks), and have been associated with smaller geographic areas affected. However, the spatial distribution of the disease appeared to be relatively stable in the northern and southern Kazakh oblasts during the study period.
From a genetic perspective, B. anthracis in Kazakhstan was dominated by isolates clustering in the MLVA A1.a group, which is consistent with reports of the A1.a group being widely distributed globally (4, 5, 6) . The widespread occurrence and apparent ecologic establishment of these VNTR genotypes in Kazakhstan supports the hypothesis that the A1.a group represents a very fi t strain complex (6) . Of the 8 A1.a genotypes in Kazakhstan, 5 were novel (G kz -2, -3, -4, -5, and -8) and exhibited a previously undescribed pX01 allele (G kz -5), which is not unexpected considering that this region has been underrepresented in prior MLVA-8 B. anthracis studies (4) (5) (6) (7) (8) .
SNP typing of representative isolates from the A1.a Kazakh MLVA genotypes assigns these isolates to the A.Br.008/009 SNP lineage, which is widely distributed throughout Europe and has been reported in western China (10, 18) . Notably, the SNP data differentiate the Kazakh genotypes from the related North American genotypes, which are not effectively differentiated by MLVA alone. Since the representative Kazakh isolates in this SNP study were cultured from outbreaks spanning a 50-year , our data not only expand the understanding of the geographic range of this Eurasian lineage (A.Br.008/009) but also provide insights into its historical incidence and persistence in the country. Because of sampling limitations, the extent to which this dominant lineage is represented in the northern sections of Kazakhstan, and further into Russia, is unknown. However, in a recent study B. anthracis DNA from persons affected by the Sverdlovsk accident was assigned to the A.Br.008/009 SNP subgroup (19) . Our data and the report that the Sverdlovsk strain was initially isolated in the 1950s in Kirov, Russia (19) , underscores the need to genotype additional samples in northern Kazakhstan oblasts and Russia to measure the northern range of this apparently highly successful lineage.
The assignment of Kazakh isolates to the A3.b and A4 MLVA clades and the A.Br.Ames and A.Br.Vollum SNP groups is not surprising considering these MLVA and SNP types are also found in Middle Eastern countries, such as Pakistan and China (10) . As fi rst reported by Van Ert et al. (10) , and later detailed by Simonson et al. (18) , the A.Br.001/002 is common in China, whereas the closely related A.Br.Ames SNP lineage is more restricted geographically. The fi nding that the Kazakh isolates from the eastern border were assigned to A.Br.Ames SNP group is notable considering that the A.Br.Ames isolates that can be geolocated are found exclusively in Inner Mongolia. These genotypic similarities may refl ect historical trade and nomadic routes linking those regions.
The absence of B lineage genotypes in Kazakhstan, as indicated by both MLVA and SNP data, is consistent with the lack of these genotypes in China, including the western province of Xinjiang (10, 18) , and supports the hypothesis that these lineages are restricted to narrow environmental conditions and, therefore, are more restricted in their global distribution (9). On a more local level, our MLVA data permit strain-level analysis of samples isolated during outbreaks. In several instances we were able to link strains collected from human anthrax patients to the infection source. For example, we identifi ed the same strain in 10 cultures collected from an outbreak in western Kazakhstan that occurred from July-August 2005. The samples included cultures isolated from livestock, contaminated meat, human victims, and contaminated soil. The MLVA data linked the cultures and provided a mechanism for retrospective epidemiologic trace-back.
Sampling biases and limitations are important considerations in any study. For example, the distribution of cultures available for this study does not represent a balanced sampling of the entire country. There is an ongoing effort in Kazakhstan to expand the culture collection and to include a wider geographic sampling of the country, including the northern oblasts, which is underrepresented in the current culture collection but has a long historical record of anthrax. It would be worthwhile to revisit livestock burial sites and to isolate and analyze cultures from this region. In addition, the application of more comprehensive genetic analysis of Kazakh isolates would provide greater insight into the uniqueness of B. anthracis diversity in this region. For example, although canonical SNPs provide a powerful tool for assigning isolates into major clonal lineages, their resolution is limited by the use of relatively few representative SNPs and the diversity of the genomes used in the initial discovery process.
In summary, our work describes the historical incidence, distribution, and biochemical and genetic diversity of B. anthracis isolates in the central Asian republic of Kazakhstan. Our discovery of novel genotypes in this region contributes to the understanding of the global diversity of the pathogen and emphasizes the need for future studies in this geographic region. In addition, this study provides useful baseline data for future epidemiologic studies in Kazakhstan and for guiding future disease control programs 
